Experimental lymphoma therapy trial ends early after enrolling just one patient
NCT ID NCT05994157
First seen Mar 28, 2026 · Last updated Jun 12, 2026 · Updated 10 times
Summary
This early-stage trial tested a two-step radiation treatment for people with non-Hodgkin lymphoma that had come back or stopped responding to standard therapies. The treatment uses a special protein to deliver radiation directly to cancer cells. Only one person enrolled before the study was stopped, so we don't have enough information to know if it works or is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Corewell Health-BAMF Health
Grand Rapids, Michigan, 49503, United States
-
East Carolina University Leo W. Jenkins Cancer Center
Greenville, North Carolina, 27834, United States
-
HonorHealth
Scottsdale, Arizona, 85258, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Stony Brook Cancer Center
Stony Brook, New York, 11794, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.